Tenascin-C (TNC) is involved in aortic disease pathophysiology. This study aims to evaluate TNC's value for predicting in-hospital deaths in acute aortic dissection (AD).
A cute aortic dissection (AD) is a catastrophic vascular disease with aortic medial layer degeneration, characterized by acute onset, rapid development, and high morbidity and mortality. Data has shown an untreated mortality of approximately 1%-2% per hour following symptom onset. 1, 2) Therefore, fast diagnosis and prognosis estimates were challenging for emergency department physicians. In the past decades, D-Dimer (DD) and C-reactive protein (CRP) focused on evaluating acute AD prognosis. However, DD specificity was low when patients presented with false lumen thrombosis, less extensive disease, and younger ages.
3) CRP was easily influenced by acute infection, trauma, and bleeding. 4) Therefore, a novel biomarker with superior performance for predicting in-hospital death from acute AD is required.
As an extracellular matrix glycoprotein, Tenascin-C (TNC) is spare in normal tissue but highly expressed in tissue during embryonic development, wound healing, mechanical stress, and cancer invasion. 5, 6) Recently, several clinical studies have shown the TNC level was associated with an adverse prognosis, severity of myocardial injury, inflammation in primate hearts, and the occurrence of major cardiovascular events in patients with cardiovascular disease. [7] [8] [9] However, whether serum TNC provided some clinical information for predicting in-hospital death from acute AD was unclear. Therefore, this study's aim was to investigate serum TNC levels in acute AD and assess their value in predicting in-hospital risk of death.
Methods
Study population: This prospective study was conducted in Second Xiangya Hospital, an affiliated Hospital of Central South University. Between December 2015 and August 2017, 109 consecutive acute AD patients (78 patients who survived and 31 who died during hospitalization) were enrolled and divided into survivor and non-survivor groups. The inclusion criteria included acute AD, presenting within 14 days of symptom onset and CT with contrast confirming a dissected descending aorta. Exclusion GUO, ET AL criteria included pregnancy, coronary heart disease, heart failure, chronic liver disease, renal disease, Marfa syndrome, trauma, and infectious diseases. The study procedure was approved by the Hunan Assurance Committee at Second Xiangya Hospital of Central South University, and informed consent was obtained from all patients. Diagnosis definition: AD diagnosis was confirmed in all patients by multi-detector computed tomography scan. We classified AD according to the Stanford classification. According to the time from onset of symptoms to admission, dissection was defined as acute AD if the time from symptom onset to admission was fewer than 14 days, while chronic AD was more than 14 days. 10) Hypertension was identified by clinic records of systolic blood pressure "140 mmHg and/or diastolic blood pressure "90 mmHg, or the use of antihypertensive agents before initial admission. Diabetes mellitus was indentified by clinic records of fasting glucose levels "126 mg/dL, glycosylated hemoglobin A1c "6.5%, or treatment with oral hypoglycemic agents or insulin. Marfan syndrome was defined using Ghent criteria.
11)
Measurements: 5 mL venous blood was collected from each patient on admission and added to pro-coagulation tubes. Blood samples were centrifuged at 3,000 r/minute for 5 minutes. Subsequently, serum was collected and stored at −80 . Serum TNC and CRP were examined by an enzyme-linked immunosorbent assay with full automatic specific protein analyzer (Beckman Coulter company, USA). The CRP reference range was 0-8 μg/mL. The plasma DD level was examined via immunoturbidimetric assay by stago compact blood coagulation analyzer (Stago Corporation, France). The reference range was ! 0.55 μg/mL.
The endpoint of the study was defined as all-cause death during hospitalization.
Statistical analysis:
Continuous normally distributed data were expressed as mean ± standard deviation; two-group comparisons were performed by the unpaired t test. Nonnormally distributed data were expressed as medians (interquartile range). Two-group comparisons were performed, non-parametrically, by Mann-Whitney U test. Frequencies were compared by Fisher's exact test. Univariate analysis and multiple logistic regression analysis were applied simultaneously to factors associated with in-hospital death from aortic dissection. Receiver operating characteristic analysis was performed to determine the cut-off value for TNC, DD, and CRP for predicting in-hospital mortality with sensitivity and specificity. All P values were twotailed, with P value < 0.05 was considered statistically significant. Statistical analysis was performed by IBM SPSS 25.0 software (IBM, Armonk, New York).
Results

Subject Characteristics:
In the present study, 109 patients with acute AD, including 78 survivors and 31 nonsurvivors, were enrolled during hospitalization. In these non-survivors, 28 patients died of aortic rupture, 2 died of heart disease, and another died of complication from aortic dissection. Compared to survivors, the percentage of type A AD (51.3% versus 80.6%, P < 0.01), the median of TNC (75.3 versus 141.1 pg/mL, P < 0.001), CRP (13.40 versus 19.20 mg/L, P < 0.001), DD (4.58 versus 8.74 μg/mL, P < 0.001) levels were significantly higher in the non-survivor group. No significant difference between the survivor and non-survivor groups in age, gender, hypertension, diabetes mellitus, coronary heart disease, smoking, alcohol use, admission SBP, admission DBP, open surgery. All data are shown in Table I . The dynamic change of TNC, CRP, and DD levels at The time from onset to admission was recorded, and these biomarkers were determined on admission. These time points were divided into four subgroups: 0-6 hours, 6-12 hours, 12-24 hours, and 24-48 hours. In these patients, there are 11 patients at 0-6 hours from onset to admission, 22, 43, 32 patients at 6-12 hours, 12-24 hours, and 24-48 hours, respectively. The serum TNC levels peaked at 12-24 hours and decreased to normal at 24-48 hours, as did the serum DD levels. Serum CRP at 12-24 hours was higher than other subgroups ( Figure 1 ). Univariate analysis and multiple logistic regression analysis for in-hospital death: Univariate analysis revealed there were four variables associated with inhospital death of acute AD, and these variables included the types of AD, TNC, DD, and CRP with a P value below 0.1 (Table II) . Subsequently, we put these four variables into multiple logistic regression analysis and found that TNC (OR, 1.038; 1.017-1.055, P < 0.001), DD (OR, 1.386; 1.107-1.643, P < 0.001), and CRP (OR, 1.084; 1.009-1.165, P < 0.001) were significantly associated with in-hospital death. Additionally, type of AD (OR, 4.722; 1.094-20.371, P < 0.05) is also related to in-hospital death from aortic dissection. All data were shown in Table   III .
AUCs in predicting in-hospital death of acute AD:
ROC analysis revealed that the AUCs of TNC in predicting in-hospital death was comparable to DD (P > 0.05) and better than CRP (P < 0.05). Furthermore, TNC specificity was better than these two variables. The cut-off values of TNC were 103.4 ng/mL. The AUCs is 0.884 (95% Cl 0.809-0.937; P < 0.0001), with sensitivity and specificity in predicting in-hospital death were 83.87% and 83.33%, respectively (Table IV, Figure 2 ).
Combination of TNC and DD in prediction of inhospital death:
To explore whether a combination of TNC and DD or CRP improve the ability to predict inhospital death from aortic dissection, a logistic regression model was built. Compared to TNC alone, the AUCs of the combination of TNC and DD for predicting in-hospital death in acute AD significantly increased (0.884 versus 0.946, P < 0.05), with sensitivity and specificity in predicting in-hospital death at 90.30% and 88.46% (95%Cl 0.885-0.980; P < 0.0001). In addition, performance characteristics were also improved (Table IV, Figure 2) .
Discussion
The present study demonstrated that serum TNC levels in the non-survivor group was significantly higher than in the survivor group, and serum TNC was comparable to DD and superior to CRP in predicting in-hospital death from acute AD. Compared to TNC alone, the combination of TNC and DD would significantly improve the performance accuracy of predicting in-hospital death from acute AD.
The destruction of extracellular matrix (ECM) in the medial layer of the aortic wall is the main pathological change in aortic dissection. It involved some upregulated extracellular proteins, such as MMPs, proteoglycan, and GUO, ET AL TNC. 6, 12, 13) TNC is an ECM glyco-protein that is synthesized by various cell types, including vascular smooth muscle and fibroblasts, in response to inflammatory cytokines and mechanical stress. 14) Accumulating evidence revealed that TNC played a vital role in the development and progress of vascular disease. Elevated serum TNC was confirmed in pulmonary arterial hypertension, restenosis, and aortic aneurysm patients. 15) Recently, Terasaki, et al. found that increased serum TNC levels indicate the severity of heart failure, left ventricular dysfunction, and remodeling in patients with dilated cardiomyopathy. 16 ) Furthermore, serum TNC levels increased in aortic dissection, and they were correlated to the peak of hsCRP and DD at day 7. 17) In the present study, we found that serum TNC levels peaked at 12-24 hours and decreased to normal at 24-48 hours. The medium serum TNC levels were significantly higher in non-survivors than survivors, which indicated that the serum TNC levels were correlated with the severity of acute AD. These results were similar to Kimura, et al.'s research, in which they reported that TNC levels were correlated with the diameter and histological destruction of the aortic wall.
18) Additionally, in human abdominal aortic aneurysm specimens, a strong and patch TNC staining was observed in the most dilated region of the aneurysm accompanied by severe tissue destruction. 19, 20) Subsequently, elevated TNC expression in aortic tissue released into blood, resulting in the elevated serum TNC levels. In addition, multiple logistic regression analysis revealed that serum TNC was an independent factor in predicting in-hospital death from acute AD. ROC analysis showed that the AUC of TNC was comparable to DD and superior to CRP in predicting inhospital death, when TNC !103.4 ng/mL, the sensitivity was 83.87%, and the specificity increased to 83.33%. DD is a small protein fragment that is the product of fibrin degradation after a blood clot degraded by fibrinolysis. 20) Previous studies demonstrated that DD was a good rule-out tool for acute AD, and acute AD would be excluded when DD levels were below 0.1 μg/mL with a sensitivity of 100%. 21) Recently, increased DD levels were observed in patients with type A acute AD, those who died during hospitalization, or those with severe complications. Its values had some relationships with the length, the size, and the features of the lesion in the dissected aorta. 22) In the present study, we found plasma DD levels in nonsurvivors were higher than in survivors. When DD was ! 5.92 μg/mL, the sensitivity and specificity in predicting in-hospital death were 87.19% and 64.70%, respectively. The sensitivity of predicting in-death hospital was lower than in previous research. The possible reasons for the low sensitivity of DD for acute AD might be the weakly negative correlation with small sample sizes and a selection bias, although the exact reason was unknown. Another explanation was that some patients with false lumen thrombosis, less extensive disease, and younger ages were enrolled.
CRP is a non-specific inflammatory protein which is produced in the liver by stimulating various cytokines. CRP values were significantly higher in patients with complications from acute AD, such as impaired oxygenation, pleural effusion, and in patients who died during hospitalization. CRP levels above 15 mg/L were an important indicator of impaired oxygenation and poor prognosis. 4) Schillinger, et al. demonstrated that CRP was an independent predictor of poor prognosis in patients with acute AD. When the CRP value was over 6.3 mg/L, the short-term risk of death was significantly high. 23) In the present study, we further confirmed that CRP was a significant indictor for predicting in-hospital death from acute AD. When CRP !14.30 mg/L, the sensitivity and specificity for predicting in-hospital death were 87.10% and 53.85%, respectively.
Recently, a combination of different biomarkers was proposed to improve the accuracy of predicting disease. For example, Giachino, et al. reported that a combination of MMP-8 and DD can increase the AUC of ROC curve of predicting acute AD. 24) In the present study, TNC, DD, and CRP were independent predictors of in-hospital death in acute AD, so we investigated whether a combination of TNC and DD or CRP can improve the performance of predicting in-hospital death from acute AD. Compared to TNC alone, the AUC's combination of TNC and DD was up to 0.946, and the sensitivity and specificity were 90.30% and 86.60%. These data demonstrated that TNC can enhance DD's ability to evaluate prognosis of shortterm outcomes in acute AD. Study limitation: Some limitations existed in this study. First, an onset time less than 48 hours was not enough to uncover the relationship between TNC and acute AD. The TNC fluctuation at different time points in different individuals was more profound to research. There was no information on the dynamic fluctuation and peak serum concentrations of these biomarkers. Second, the present study was a single-center study; a multi-center study needs to be performed in future. Finally, we only observed the role of serum TNC for predicting in-hospital mortality; longer follow up and the effects of these biomarkers on survival time from aortic dissection are needed.
Conclusion
This study demonstrates that TNC is useful for evaluating in-hospital death of acute AD. Furthermore, a combination of TNC and DD is more effective for improving the accuracy of predicting in-hospital death in acute AD.
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